BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Immvention Therapeutix Inc.

Headquarters: Durham, NC, United States
Year Founded: 2017
Status: Private

BioCentury | Jan 28, 2025
Deals

Abbvie seeks molecular glue degraders from Neomorph

Also in BioCentury’s Deals Report, Novo licenses BACH1 inhibitor from Immvention, Arrivent-Lepu in ADC deal, and Sage rejects Biogen’s bid
Items per page:
1 - 1 of 1
Help Center
Username
Request Training
Submit Data Correction
Ask a Question